SXLV:SW:SW-SPDR S&P U.S. Health Care Select Sector UCITS ETF (Acc) (USD)

ETF | Others |

Last Closing

USD 40.805

Change

0.00 (0.00)%

Market Cap

N/A

Volume

608.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHDIV:SW UBS ETF (CH) - MSCI Switzerlan..

+0.01 (+0.04%)

USD 1,244,681.59B
SPISI:SW UBS ETF (CH) - SPI® ESG (CHF)..

+0.03 (+0.18%)

USD 590,186.66B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

+0.06 (+0.26%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

+0.11 (+0.37%)

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

N/A

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

-84.00 (-1.28%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

-13.50 (-0.66%)

USD 134,034.86B
RGLDO:SW Raiffeisen ETF Solid Gold Ounc..

-9.00 (-0.35%)

USD 134,034.85B
SPICHA:SW UBS ETF (CH) – SPI® (CHF) A..

-0.06 (-0.08%)

USD 131,872.43B

ETFs Containing SXLV:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.17% 25% F 26% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.17% 24% F 25% F
Trailing 12 Months  
Capital Gain -6.59% 12% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.59% 11% F 16% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.23% 51% F 54% F
Dividend Return 5.23% 51% F 53% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.18% 60% D- 65% D
Risk Adjusted Return 72.86% 52% F 57% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike